Fineotex Chemical Limited

As of June 30, 2026, Fineotex Chemical Limited carries a market capitalization of 45.18B, placing it among publicly traded companies globally. Its enterprise value stands at 45.18B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Fineotex Chemical Limited's next confirmed earnings release is scheduled for November 2, 2026.

As of June 30, 2026, Fineotex Chemical Limited has 1.16B shares outstanding.

As of June 30, 2026, Fineotex Chemical Limited trades at a trailing price-to-earnings ratio of 31.13.

As of June 30, 2026, Fineotex Chemical Limited trades at an EV/EBITDA multiple of 26.78 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 4.47 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 29.42 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 45.18B versus a market cap of 45.18B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 34.65M in revenue per employee across its workforce of 292.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Fineotex Chemical Limited recorded 380.89M in income tax expense. That works out to an effective tax rate of 20.45, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 1.86B, leaving 1.22B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Fineotex Chemical Limited's stock has gained approximately 109.64% over the past 52 weeks. The 50-day moving average sits at 52.90, while the 200-day moving average is 35.39.

Over the twelve months ended June 30, 2026, Fineotex Chemical Limited generated 10.12B in revenue and converted that into 1.22B in net income, yielding earnings per share of 1.51. EBITDA reached 1.69B, while operating income came in at 1.54B.

Over the twelve months ended June 30, 2026, Fineotex Chemical Limited posted a gross margin of 33.83, reflecting its pricing power and cost economics. The operating margin of 15.18 and net profit margin of 12.09 provide insight into operational efficiency.

Fineotex Chemical Limited's most recent stock split took place on October 31, 2025 with a 1:10 split ratio.